HGSI: I WARNED...doctors are saying what we all have read in fda documents. Limited efficacy, safety woes, uncertain northamerican key data...anyway having GSK as partner will allow HGSI to retest drug, maybe in 2yrs another bla, but I hope fda allowing benlysta for compassionate use to late stage patients, only ones admitted to deserve a chance of recovery right now.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.